Adsorption of Naphthalene, Phenanthrene and Pyrene from Aqueous Solution Using Low-Cost Activated Carbon Derived from Agricultural Wastes

In this work, the adsorption of polycyclic aromatic hydrocarbons (PAHs) from aqueous solution by rice husk activated carbon (RHAC) was compared with adsorption using conventional, powdered activated carbon as the adsorbent. The adsorbent capacity of RHAC was found to be higher than all other agricultural and industrial adsorbents evaluated. The kinetics of PAHs was similar even after 24 hours. The removal of PAH occurred in the following order: naphthalene < phenanthrene < pyrene. Our study results show that molecular weight and solubility play vital roles in the adsorption of PAH on RHAC. The study results pointed to the occurrence of an intra-particle mechanism in all cases. The isotherm models that best represented the data obtained were Freundlich for naphthalene, Redlich–Peterson for phenanthrene, and Langmuir for pyrene. The results of this study were compared with previous studies

Inversvoltammetrie des Technetiums im Tetraphenylarsoniumchlorid-Chloroform-Extrakt am haengenden Quecksilbertropfen

SIGLECopy held by FIZ Karlsruhe; available from UB/TIB Hannover / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekDEGerman

Evidence of a tumour suppressor function for DLEC1 in human breast cancer.

DLEC1 (deleted in lung and oesophageal cancer), located on 3p22.3, is a candidate tumour suppressor gene in lung, esophageal, and renal cancer. The aim of this study was determine whether the mRNA expression levels of DLEC1 were consistent with a tumour suppressive function. MATERIALS AND METHODS: A total of 153 samples were analysed. The levels of transcription of DLEC1 were determined using quantitative PCR and normalised against (CK19). Transcript levels within breast cancer specimens were compared to normal background tissues. RESULTS: Levels of transcription were lower [corrected] in tumour samples compared to adjacent non cancerous tissue (ANCT) samples but this was not statistically significant (median 0.167 vs. 0.03; p=0.138). DLEC1 expression levels were significantly lower in samples from patients who developed metastasis, local recurrence, or died of breast cancer when compared to those who were disease free for >10 years (p=0.041). DISCUSSION: These findings are consistent with a possible tumour suppressor function of DLEC1 in breast cancer